Sebbin Benelux SPRL
Sebbin Benelux reported total assets of 224,866 € at the end of the 2024 financial year (annual accounts filed with the NBB on 31 Mar 2025).
The score of Sebbin Benelux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +4 % Total assets -28 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sebbin Benelux's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 31 Mar 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 20 May 2022
- Year ended 31 Dec 2020filed on 30 Jul 2021
Sebbin Benelux's financial analysis
- Solvency95.2%sector median: 22.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sebbin Benelux
Sebbin Benelux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0841.719.676
- VAT number
- BE0841719676
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 12 Dec 2011
- Registered office
- 1050 Ixelles
- Latest accounts
- 2024 · filed on 31 Mar 2025
- Activity
- Activities of agents involved in the wholesale of other particular products (NACE 4618032)
Sebbin Benelux (SPRL) has been based in Ixelles since 2011, active in: activities of agents involved in the wholesale of other particular products. For 2024, it reports a net loss of 15,822 € and equity of 214,010 €; its revenue is not published. Its solvency stands at 95.2%, above the median of its sector (22.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sebbin Benelux
Companies in the same business, of comparable size and area, outside its group.
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- Zenim Wholesale of pharmaceutical and medical goods Tenneville · balance sheet 224,171 €
Frequently asked questions about Sebbin Benelux
What is the revenue of Sebbin Benelux?
Sebbin Benelux files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Sebbin Benelux?
In Belgium, the VAT number is the company number prefixed with BE: BE0841719676 for Sebbin Benelux, if the company is VAT-registered. Its company number (CBE) is 0841.719.676.
Where is the registered office of Sebbin Benelux?
According to the CBE register, the registered office of Sebbin Benelux is in 1050 Ixelles.
What is the equity of Sebbin Benelux?
At the close of the 2024 financial year, the equity of Sebbin Benelux amounts to 214,010 €, a solvency of 95.2% of total assets.
Who manages Sebbin Benelux?
The register lists 2 active mandates at Sebbin Benelux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sebbin Benelux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →